World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Uncategorized

FIZE Medical Announces Prof. John A. Kellum, MD, MCCM, Has Joined Its Scientific Advisory Board

Cision PR Newswire by Cision PR Newswire
February 19, 2026
in Uncategorized
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Renowned critical care leader to support advancement of early prediction and intervention in ICU fluid management

NEW YORK, Feb. 19, 2026 /PRNewswire/ — FIZE Medical, a medical technology company focused on smart fluid management in critical care, announced the appointment of Prof. John A. Kellum, MD, MCCM, to its Scientific Advisory Board. Prof. Kellum will provide clinical and scientific expertise as FIZE Medical continues to develop data-driven solutions designed to improve fluid management for critically ill patients.


Dror Zerem, CEO FIZE Medical

Prof. Kellum’s research focuses on critical care nephrology, acute kidney injury (AKI), sepsis, multi-organ failure, and clinical epidemiology, with particular emphasis on consensus development and research methodology. He is widely recognized as a global authority in these fields.

The addition of Prof. Kellum further strengthens the Scientific Advisory Board’s expertise across kidney function and critical care physiology, reinforcing the scientific rigor and strategic framework guiding FIZE Medical’s technology development.

“We are honored to have Prof. Kellum join our Scientific Advisory Board,” said Dror Zerem, CEO of FIZE Medical. “Prof. Kellum is a distinguished expert renowned for his groundbreaking contributions to fluid management in critical care. His guidance will be invaluable as we advance smart fluid management solutions that help clinicians make earlier, more informed decisions.”

Prof. Kellum is a Distinguished Professor of Critical Care Medicine, Medicine, Bioengineering, and Clinical and Translational Science at the University of Pittsburgh, where he holds an endowed Chair in Critical Care Research and serves as Director of the Center for Critical Care Nephrology in the Department of Critical Care Medicine.

He has authored more than 750 scientific publications and is among the most highly cited investigators in critical care medicine. Prof. Kellum has delivered over 500 invited lectures worldwide and has received numerous awards for excellence in teaching and research. He is ranked the #1 expert in the world for Acute Kidney Injury by Expertscape (since 2017) and is the 2026 recipient of the Bywater’s award for Acute Kidney Injury from the International Society of Nephrology (ICN).

About FIZE Medical

FIZE Medical is an innovative MedTech company dedicated to transforming fluid management for critically ill patients. Its proprietary FIZE kUO® system, commercially available in the U.S., provides real-time, digital monitoring to support precision fluid management, early intervention, and improved patient outcomes. FIZE Medical is committed to redefining fluid management through continuous innovation, AI-driven data insights, and clinical evidence.

Contact:

Eran Blankenstein
eranblank@fizemedical.com 

Photo – https://mma.prnewswire.com/media/2916721/Dror_Zerem.jpg
Photo – https://mma.prnewswire.com/media/2916720/John_A_Kellum.jpg


John A. Kellum, MD, MCCM

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/fize-medical-announces-prof-john-a-kellum-md-mccm-has-joined-its-scientific-advisory-board-302692696.html

SOURCE FIZE Medical

Cision PR Newswire

Cision PR Newswire

Related Posts

Your Wearable Is Watching Your Body. Here Is What It Is Missing About Your Brain.

Your Wearable Is Watching Your Body. Here Is What It Is Missing About Your Brain.

July 20, 2026
love around the world cultures

Love Around the World: How Different Cultures Define Romance

March 17, 2026
Oscars 2026 fashion

The Best Oscars 2026 Red Carpet Fashion Moments That Defined the Night

March 16, 2026
eating disorders

Eating Disorders in Women: What Is Really Going On and Where to Get Help

March 16, 2026
Mels Robins skin care

The Dermatologist Skincare Routine That Actually Works

March 16, 2026

Ulike Spring: Dare to Glow — Celebrating Confident and Aspirational Women

March 9, 2026

Popular News

  • ASF Launches Nicotine Pouch Brand ‘LOOP’ in South Africa, Expanding Across Africa

    0 shares
    Share 0 Tweet 0
  • China-ASEAN Education Cooperation Week 2026 Unveils Major Initiatives

    0 shares
    Share 0 Tweet 0
  • UD info Launches One-Stop Industrial-Grade SD and microSD Card Solutions

    0 shares
    Share 0 Tweet 0
  • GlycoNex Doses First Patient in Phase I Trial of GNX1021, Advancing Its Glycan-Directed ADC into Clinical Development

    0 shares
    Share 0 Tweet 0
  • Shui On Land Named Among TIME’s World’s Most Impactful Companies 2026

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler